Dysphagia, QoL and Attitudes Towards PEG in ALS Patients

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Rehabilitation Institute, Republic of Slovenia

About this trial

In Amyotrophic Lateral Sclerosis, dysphagia has a high incidence. With deterioration of swallowing function, percutaneous endoscopic gastrostomy (PEG) tube is recommended to ensure sufficient and safe oral intake. Dysphagia and PEG placement alter quality of life (QoL). However, QoL and attitudes toward PEG remain largely unexplored. The purpose of this study is to monitor the swallowing function in relationship to QoL and attitudes toward PEG tube insertion and feeding.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

18 years of age or older

diagnosis of ALS

follow-up at University Medical Centre Ljubljana, Division of Neurophysiology, every 3 months

be able to visit the study site for in-person procedures every 3 months

Disqualifiers

co-existing illness or disorder that could influence the swallowing function independently of the ALS diagnosis

clinically significant cognitive deterioration or dementia at enrollment, as determined by the ALS study neurologist

signs of probable cognitive deterioration or dementia at enrollment

Trial population

The study will include adult ALS patients able to visit the study site for in-person procedures every 3 months, and their close relatives.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Iowa Oral Performance Instrument (IOPI)

    Diagnostic test

    IOPI measures the peak pressure of the tongue strength and endurance using a disposable bulb placed on a hard palate behind the front teeth or at the base of the tongue. The participants will be asked to press the bulb with their tongue with maximum pressure, three times. To measure the endurance, the participants will be asked to hold the pressure for as long as they can.

  • Mann Assessment of Swallowing Ability (MASA)

    Diagnostic test

    MASA is a standard clinical swallowing assessment protocol including general patient examination, on-the-outside visible signs of oral preparatory and transportation phase and pharyngeal phase of swallowing function.

  • Fiberoptic Endoscopic Evaluation of Swallowing

    Diagnostic test

    The subjects will ingest up to 10 boluses ranging in thickness and volume (from thin to extremely-thick and a cookie).

  • Respiratory function measurements

    Diagnostic test

    Respiratory function measurements will include forced vital capacity (FVC), maximum inspiratory pressure (MIP), and maximum expiratory pressure (MEP), all expressed in percentage of predicted values. Conventional methods of testing will be applied.

Treatment groups

60 Participants
are divided into 2 treatment groups
Group A: ALS Patients4 interventions
Group B: Relatives0 interventions

Trial outcomes

Primary outcomes

1

Penetration-Aspiration Scale (PAS) change

PAS is an 8-point scale used to determine swallowing safety. Levels 1 and 2 are considered safe, levels \>3 indicate penetration or aspiration and are considered unsafe.

Time frame
Difference between baseline and PEG insertion (usually in 6-25 months after diagnosis, maximum follow-up 30 months)
2

Yale Residue Severity Rating Scale (YRSRS) change

YRSRS is a validated measure of swallowing efficiency using an image-based assessment to determine post-swallow pharyngeal residue: location and severity. It is assessed using a 5-point ordinal scale (from 1=0 % residue to 5=50 % residue).

Time frame
Difference between baseline and PEG insertion (usually in 6-25 months after diagnosis, maximum follow-up 30 months)
3

Iowa Oral Performance Instrument (IOPI) change

IOPI is a device which measures tongue strength (in kilopascals; kPa) and endurance (in seconds) while the participant presses the bulb with the front or the base of their tongue to the hard palate.

Time frame
Difference between baseline and PEG insertion (usually in 6-25 months after diagnosis, maximum follow-up 30 months)
4

Mann Assessment of Swallowing Ability (MASA) change

MASA is a standard clinical swallowing assessment protocol administered by the speech-language therapist. Total score ranges from 38-200. Lower score indicates higher impairment.

Time frame
Difference between baseline and PEG insertion (usually in 6-25 months after diagnosis, maximum follow-up 30 months)

Secondary outcomes

1

ALS Functional Rating Scale-Revised (ALSFRS-R) change

ALSFRS-R is a 12-tem ALS-specific assessment of global functioning using a five-point scale (0=not able, 4= normal ability), with 48 points representing normal function.

Time frame
Difference between baseline and PEG insertion (usually in 6-25 months after diagnosis, maximum follow-up 30 months)
2

Functional Oral Intake Scale (FOIS) change

FOIS is a validated 7-point scale demonstrating an individual's ability of daily oral food intake (1=no oral intake, 7=total oral intake with no restrictions).

Time frame
Difference between baseline and PEG insertion (usually in 6-25 months after diagnosis, maximum follow-up 30 months)
3

Dysphagia Outcome and Severity Scale (DOSS) change

DOSS is a 7-point scale that rates the functional severity of dysphagia based on objective assessment and provides information on diet recommendations, independence level and type of nutrition necessary (level 7=normal swallowing function, level 1=severe dysphagia).

Time frame
Difference between baseline and PEG insertion (usually in 6-25 months after diagnosis, maximum follow-up 30 months)
4

BMI change

Body mass index (in kg/m\^2)

Time frame
Difference between baseline and PEG insertion (usually in 6-25 months after diagnosis, maximum follow-up 30 months)

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University Rehabilitation Institute, Republic of Slovenia

Lead sponsor

University Medical Centre Ljubljana

Collaborator